Lin BioScience (ROCO:6696) Net Change in Cash : NT$1,615.82 Mil (TTM As of Jun. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Lin BioScience Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Lin BioScience's Net Change in Cash for the six months ended in Jun. 2023 was NT$309.58 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Jun. 2023 was NT$1,615.82 Mil.

Lin BioScience Net Change in Cash Historical Data

The historical data trend for Lin BioScience's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lin BioScience Net Change in Cash Chart

Lin BioScience Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Change in Cash

Get a 7-Day Free Trial

-50.85

975.11

-285.40

838.39

1,615.82

Lin BioScience Semi-Annual Data
	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Net Change in Cash	Get a 7-Day Free Trial										-148.31	1,022.31	-183.93	309.58	1,306.24

Lin BioScience Net Change in Cash Calculation

Lin BioScience's Net Change in Cash for the fiscal year that ended in Dec. 2023 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	-1012.818	+	1.866	+	2636.911	+	-10.137
	=	1,615.82

Lin BioScience's Net Change in Cash for the quarter that ended in Jun. 2023

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= -404.153 + 1.148 + 690.639 + 21.946

= 309.58

Net Change in Cash for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$1,615.82 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lin BioScience Net Change in Cash Related Terms
Thank you for viewing the detailed overview of Lin BioScience's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Lin BioScience (ROCO:6696) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lin BioScience Inc (ROCO:6696) » Definitions » Net Change in Cash

Comparable Companies

TPE:1760 ROCO:6535 ROCO:6885 ROCO:6875 TPE:6541 ROCO:4157 ROCO:4728 ROCO:4726 ROCO:6838 ROCO:3176 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX

Traded in Other Exchanges

N/A

Address

Zhongxiao East Road, 12th Floor, No. 68, Section 5, Xinyi District, Taipei City, TWN, 110

Website

https://www.linbioscience.com

Lin BioScience Inc is a drug development company. It specializes in therapies for diseases with unmet medical needs. Its novel pipeline consists of first-in-class drugs aimed at treating life-threatening or disabling diseases in oncology, ophthalmology, cardiovascular, and metabolic disease.

Lin BioScience (ROCO:6696) Headlines

No Headlines